<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical manifestation and immunoserological features of <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> (SAPS) were analyzed in this paper in 107 patients with systemic <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the group of patients with confirmed <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) were positive in 43/93 (46.23%), while in 50/93 (53.76%) they were negative </plain></SENT>
<SENT sid="2" pm="."><plain>Among aPL positive patients, 33/43 (76.74%) had clinical manifestations of SAPS, while 10 patients (23.26%) were without any clinical manifestations </plain></SENT>
<SENT sid="3" pm="."><plain>The most frequent manifestations of SAPS associated with SLE were: arteriovenous <z:mp ids='MP_0005048'>thrombosis</z:mp> in 20/43 (46.51%), thrombocitopenia in 15/43 (34.88%) and <z:hpo ids='HP_0001890'>autoimmune hemolytic anemia</z:hpo> in 7/43 (16.27%) </plain></SENT>
<SENT sid="4" pm="."><plain>In our patients, rare manifestations of SAPS associated with SLE were recurrent fetal loss (1 case), <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> (1 case), transversal <z:e sem="disease" ids="C0026975" disease_type="Disease or Syndrome" abbrv="">myelitis</z:e> (2 cases), <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> (2 cases) and aseptic <z:hpo ids='HP_0100584'>endocarditis</z:hpo> (Libman-Sacks) (5 cases) </plain></SENT>
<SENT sid="5" pm="."><plain>Among 7 patients, with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren's syndrome</z:e>, clinically manifested SAPS was observed in 2, while in other 5 only increased aPL levels were found, as well as in patients with systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo>-3, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCTD</z:e>-2 and Sy </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjögren</z:e> with <z:hpo ids='HP_0002633'>vasculitis</z:hpo>-1 </plain></SENT>
<SENT sid="7" pm="."><plain>One RA patient had <z:mp ids='MP_0005048'>thrombosis</z:mp> of v. cava inferior </plain></SENT>
<SENT sid="8" pm="."><plain>In majority of patients with clinically present SAPS the levels of both examined immunoglobulin isotypes (IgG + IgM) were decreased-21/40 or 52.5%, while isolated increase of IgG was found in 14 (35%) and isolated increase of IgM in 5 (19.22%) patients </plain></SENT>
<SENT sid="9" pm="."><plain>In three out of five patients with Libman-Sacks only LA test was positive </plain></SENT>
<SENT sid="10" pm="."><plain>This investigation have shown that arterial and venous thromboses are the most common manifestations of SAPS in SLE </plain></SENT>
<SENT sid="11" pm="."><plain>Every blood vessel may be involved (from arteriolae to the aorta and from postcapilar venules to the v </plain></SENT>
<SENT sid="12" pm="."><plain>cava) </plain></SENT>
</text></document>